The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study. Issue 10 (12th October 2021) - Fei, Xiaochen; Fan, Liancheng; Chen, Wei; Chen, Wei; Gong, Yiming; Du, Xinxing; Wang, Yanqing; Zhu, Yinjie; Pan, Jiahua; Wang, Fangqin; Zhao, Wanbing; Liu, Tongtong; et al.